Resource Type

Journal Article 1

Year

2023 1

Keywords

ADCP 1

EGFR 1

anti-CD47 antibody 1

combination strategy 1

osimertinib 1

Search scope:

排序: Display mode:

CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer

Frontiers of Medicine 2023, Volume 17, Issue 1,   Pages 105-118 doi: 10.1007/s11684-022-0934-1

Abstract: The third-generation epidermal growth factor receptor (EGFR) inhibitor osimertinib (OSI) has been approved

Keywords: osimertinib     anti-CD47 antibody     combination strategy     ADCP     EGFR    

Title Author Date Type Operation

CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer

Journal Article